VASP and ischemia: First, data on cutoff values for VASP index in a setting of TAT regimen are limited, and it may well be that cutoff values that best determine patients risk for ischemia or bleeding may differ in this cohort compared with values obtained in patients with antiplatelet treatment alone [17].